Evidence map›Paper›PMID 32393914›Full record

ArticleNature biotechnology2020

Multiplex digital spatial profiling of proteins and RNA in fixed tissue.

Christopher R Merritt, Giang T Ong, Sarah E Church, Kristi Barker, Patrick Danaher, Gary Geiss, Margaret Hoang, Jaemyeong Jung, Yan Liang, Jill McKay-Fleisch and 12 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 700 papers.

0numbers the graph read from it
0cells of the map it votes in
700citing papers in PubMed
43.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

700 citing papers in PubMed, 1,036 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. A modular framework for antibody-drug conjugate biomarkers.Nature reviews. Clinical oncology · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Insights Into Spatial Transcriptomics: Exploring Recent Technical Developments and Their Diverse Applications.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Emerging technologies in the spatial proteomics landscape.Analytical and bioanalytical chemistry · 2026
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

640 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 2 institutions in 1 country.

Christopher R MerrittNanoString Technologies, Inc., Seattle, WA, USA. cmerritt@nanostring.com.
Giang T OngNanoString Technologies, Inc., Seattle, WA, USA.
Sarah E ChurchNanoString Technologies, Inc., Seattle, WA, USA.ORCID http://orcid.org/0000-0002-7194-4282
Kristi BarkerNanoString Technologies, Inc., Seattle, WA, USA.
Patrick DanaherNanoString Technologies, Inc., Seattle, WA, USA.
Gary GeissNanoString Technologies, Inc., Seattle, WA, USA.
Margaret HoangNanoString Technologies, Inc., Seattle, WA, USA.
Jaemyeong JungNanoString Technologies, Inc., Seattle, WA, USA.
Yan LiangNanoString Technologies, Inc., Seattle, WA, USA.
Jill McKay-FleischNanoString Technologies, Inc., Seattle, WA, USA.
Karen NguyenNanoString Technologies, Inc., Seattle, WA, USA.
Zach NorgaardNanoString Technologies, Inc., Seattle, WA, USA.
Kristina SorgNanoString Technologies, Inc., Seattle, WA, USA.
Isaac SpragueNanoString Technologies, Inc., Seattle, WA, USA.
Charles WarrenNanoString Technologies, Inc., Seattle, WA, USA.
Sarah WarrenNanoString Technologies, Inc., Seattle, WA, USA.
Philippa J WebsterNanoString Technologies, Inc., Seattle, WA, USA.
Zoey ZhouNanoString Technologies, Inc., Seattle, WA, USA.
Daniel R ZollingerNanoString Technologies, Inc., Seattle, WA, USA.
Dwayne L DunawayNanoString Technologies, Inc., Seattle, WA, USA.
Gordon B MillsPrecision Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA.ORCID http://orcid.org/0000-0002-0144-9614
Joseph M BeechemNanoString Technologies, Inc., Seattle, WA, USA. jbeechem@nanostring.com.
Nanostring Technologies (United States) · USOregon Health & Science University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Digital Spatial Profiling (DSP) is a method for highly multiplex spatial profiling of proteins or RNAs suitable for use on formalin-fixed, paraffin-embedded (FFPE) samples. The approach relies on (1) multiplexed readout of proteins or RNAs using oligonucleotide tags; (2) oligonucleotide tags attached to affinity reagents (antibodies or RNA probes) through a photocleavable (PC) linker; and (3) photocleaving light projected onto the tissue sample to release PC oligonucleotides in any spatial pattern across a region of interest (ROI) covering 1 to ~5,000 cells. DSP is capable of single-cell sensitivity within an ROI using the antibody readout, with RNA detection feasible down to ~600 individual mRNA transcripts. We show spatial profiling of up to 44 proteins and 96 genes (928 RNA probes) in lymphoid, colorectal tumor and autoimmune tissues by using the nCounter system and 1,412 genes (4,998 RNA probes) by using next-generation sequencing (NGS). DSP may be used to profile not only proteins and RNAs in biobanked samples but also immune markers in patient samples, with potential prognostic and predictive potential for clinical decision-making.

Indexed as

Computational BiologyGene Expression ProfilingHigh-Throughput Nucleotide SequencingHumansProteomicsSequence Analysis, RNASoftwareSpatial AnalysisTissue Fixation

Identifiers

PMID32393914
OpenAlexW3023701177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.